Discovery Laboratories, Inc. (NASDAQ:DSCO) announced that it has been awarded the final $1.9 million of a $2.4 million Fast Track Small Business Innovation Research (SBIR) Grant from the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH). Discovery Laboratories, Inc. (NASDAQ:DSCO) stock opened today at $1.76 and is currently trading at $1.75. The stock showed a negative weekly performance of -1.72%.
On June 13, 2014, EnteroMedics Inc (NASDAQ:ETRM) entered into a Sales Agreement (the “Sales Agreement”) with Cowen and Company, LLC (“Cowen”). The Sales Agreement provides that, upon the terms and subject to the conditions set forth therein, the Company will issue and sell through Cowen, acting as sales agent, shares (the “Shares”) of the Company’s common stock, $0.01 par value per share (the “Common Stock”) having an aggregate offering price of up to $25,000,000. EnteroMedics Inc (NASDAQ:ETRM) in current trading session and currently is at $1.52. The 52 week range is $1.00 – $2.66. Company’s market capitalization is $102.14 million.
Investment analysts at RBC Capital assumed coverage on shares of MannKind Corporation (NASDAQ:MNKD) in a note issued to investors on Thursday, TheFlyOnTheWall.com reports. The firm set an “outperform” rating and a $16.00 price target on the stock. RBC Capital’s price target would indicate a potential upside of 52.09% from the stock’s previous close. MannKind Corporation (NASDAQ:MNKD) stock is currently trading at $10.60. The EPS of the stock is 0.63. Company’s market capitalization is $4.12 billion.
Techne Corporation (NASDAQ:TECH) announced that it has agreed to acquire ProteinSimple for $300 million in cash. The closing of the acquisition is subject to the satisfaction of customary closing conditions, including the expiration or early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976. Techne Corporation (NASDAQ:TECH) stock opened the session at $89.50, and now is at $91.29. The 52 week range of the stock remained $66.36 – $96.96 and the day range was $89.16 – $91.43.
The Botox-maker – Allergan Inc. (NYSE:AGN), which has been a target of a 53-billion-dollar acquisition by Valeant Pharmaceuticals International Inc. – disclosed private correspondence in the form of e-mails, where Valeant was described by its own bankers as a “house of cards”. Allergan, Inc. (NYSE:AGN) stock opened today at $159.76 and is currently trading at $160.40. The stock showed a positive weekly performance of 2.38%.
Leave a Reply